You guys must not know....but you can't short NAVB due to the uptick rule. All of this selling is ENTIRELY from selling of shares outright. Sell the news has been in place.
So until the uptick rule is removed there is no shorting to be had. Better start pointing the finger somewhere else.
Lymphoseek is a 30 million product. With 150million outstanding shares fully diluted you are looking at a 450 million company.
This selling is occurring because this company ain't worth what's priced at.
You should look at the L2 ask price. Humongous sellers. Going down tomorrow too. Can't short. Damn
I am hoping that the price stays lower until Monday. I will be buying another block of shares then. I am happy that Lymphoseek got approved. I was a little nervous when they sold off the gama probe business. Cheers! I am switching my long term sentiment status to Strong Buy because of pending sales and income!
Sentiment: Strong Buy